Researcher
Bram Verstockt
- Disciplines:Gastro-enterology
Affiliations
- Translational Research in GastroIntestinal Disorders (Division)
Member
From1 Oct 2015 → Today
Projects
1 - 10 of 12
- Inflammatory bowel diseasesFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Infrastructure for Targeted ProteomicsFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Characterization of triggers of post-operative recurrence in Crohn’s disease in both the external and luminal side of the intestineFrom1 Jan 2023 → TodayFunding: FWO research project
- Exploring the gut barrier as master regulator of microbiome-host interactions in CKD patients using organoid culturesFrom11 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Development of a gut-on-a-chip model for pre-clinical testing of drugs for inflammatory bowel diseaseFrom12 Sep 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Gastroenterology > Inflammatory Bowel disease > personalised medicine; biomarkers; multi-omicsFrom1 Jun 2022 → TodayFunding: BOF - various
- The role of myeloid cells in the resolution of intestinal inflammationFrom1 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The role of eosinophils in intestinal inflammation and fibrosis in inflammatory bowel disease.From5 Mar 2020 → 5 Mar 2024Funding: Own budget, for example: patrimony, inscription fees, gifts
- “Predicting response to therapy in inflammatory bowel diseases ”From23 Sep 2019 → 23 Sep 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Interaction Between Myeloid And Stromal Cells Dictates Disease Outcome in Intestinal InflammationFrom1 Oct 2018 → 27 Jun 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
131 - 140 of 201
- Gene and Mirna Regulatory Networks During Different Stages of Crohn's Disease(2019)
Authors: Sare Verstockt, Gert De Hertogh, Bram Verstockt, Kathleen Machiels, Frans Schuit, Gert Van Assche, Marc Ferrante, Séverine Vermeire, Ingrid Arijs, Isabelle Cleynen
Pages: 916 - 930 - Ustekinumab Exposure-outcome Analysis in Crohn's Disease Only in Part Explains Limited Endoscopic Remission Rates(2019)
Authors: Bram Verstockt, Erwin Dreesen, An Outtier, Nathalie Van den Berghe, Isolde Aerden, Gert Van Assche, Ann Gils, Séverine Vermeire, Marc Ferrante
Pages: 864 - 872 - Clostridium difficile infection in inflammatory bowel disease: epidemiology over two decades(2019)
Authors: Annick Moens, Bram Verstockt, Kathleen Machiels, Peter Bossuyt, Katrien Lagrou, Gert Van Assche, Séverine Vermeire, Marc Ferrante
Pages: 668 - 673 - SYSTEMS GENOMICS OF ULCERATIVE COLITIS: COMBINING GWAS, SIGNALLING AND TRANSCRIPTIONAL NETWORKS TO UNCOVER NOVEL PATHOGENIC PATHWAYS(2019)
Authors: Johanne Brooks, Dezso Modos, Padhmanand Sudhakar, Bram Verstockt, Benjamin Alexander-Dann, Azedine Zoufir, David Fazekas, Mark Tremelling, Alastair Watson, Simon Carding, et al.
Pages: S605 - S606 - PREDICTING ENDOSCOPIC RESPONSE IN USTEKINUMAB TREATED PATIENTS WITH CROHN'S DISEASE TRHOUGH AN INTEGRATED MULTI-OMICS BIOMARKER(2019)
Authors: Bram Verstockt, Padhmanand Sudhakar, Brecht Creyns, Sare Verstockt, Gert Van Assche, Christine Breynaert, Séverine Vermeire, Marc Ferrante
Pages: S656 - S656 - IDENTIFYING MOLECULAR FEATURES CONTRIBUTING TO DISEASE HETEROGENEITY IN CROHN'S DISEASE USING MULTI-OMIC DATA INTEGRATION(2019)
Authors: Padhmanand Sudhakar, Bram Verstockt, Brecht Creyns, Jonathan Cremer, Gert Van Assche, Tamas Korcsmaros, Marc Ferrante, Séverine Vermeire
Pages: S1117 - S1117 - LONG-TERM CLINICAL EFFICACY OF USTEKINUMAB IN REFRACTORY CROHN'S DISEASE: A MULTI-CENTRE BELGIAN COHORT STUDY(2019)
Authors: Claire Liefferinckx, Bram Verstockt, Ann Gils, Maja Noman, Catherine Van Kemseke, Elisabeth Macken, Martine De Vos, Wouter Van Moerkercke, Jean-Francois Rahier, Peter Bossuyt, et al.
Pages: S882 - S883 - TREM1, THE FIRST ANTI-TNF SPECIFIC BIOMARKER GUIDING THERAPEUTIC DECISION IN INFLAMMATORY BOWEL DISEASE(2019)
Authors: Bram Verstockt, Sare Verstockt, Jonas Dehairs, Christine Breynaert, Gert Van Assche, Séverine Vermeire, Marc Ferrante
Pages: S67 - S67 - PREDICTING VEDOLIZUMAB INDUCED ENDOSCOPIC REMISSION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE VIA A SPECIFIC FOUR-GENE COLONIC SIGNATURE(2019)
Authors: Bram Verstockt, Sare Verstockt, Padhmanand Sudhakar, Jonas Dehairs, Gert Van Assche, Séverine Vermeire, Marc Ferrante
Pages: S109 - S110 - VEDOLIZUMAB INDUCED ENDOSCOPIC REMISSION IN ANTI-TNF NAIVE AND ANTI-TNF EXPOSED IBD PATIENTS: A LARGE SINGLE CENTRE EXPERIENCE(2019)
Authors: Bram Verstockt, Evelien Mertens, An Outtier, Gert A Van Assche, Séverine Vermeire, Marc Ferrante
Pages: S877 - S878
Patents
1 - 2 of 2